Escalon Medical Corp. ESMC
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 3.86M | 2.61M | 3.59M | 2.68M | 2.57M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.86M | 2.61M | 3.59M | 2.68M | 2.57M |
| Cost of Revenue | 1.91M | 1.66M | 2.04M | 1.55M | 1.45M |
| Gross Profit | 1.95M | 946.70K | 1.56M | 1.12M | 1.12M |
| SG&A Expenses | 1.25M | 1.34M | 1.33M | 1.11M | 1.20M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.29M | 3.03M | 3.49M | 2.88M | 2.94M |
| Operating Income | 568.50K | -419.30K | 98.70K | -202.80K | -371.80K |
| Income Before Tax | 641.90K | 2.37M | 97.70K | -239.90K | -379.80K |
| Income Tax Expenses | -1.14M | -- | -- | -- | -- |
| Earnings from Continuing Operations | 1.78M | 2.37M | 97.70K | -239.90K | -379.80K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.78M | 2.37M | 97.70K | -239.90K | -379.80K |
| EBIT | 568.50K | -419.30K | 98.70K | -202.80K | -371.80K |
| EBITDA | 571.50K | -416.30K | 107.20K | -194.60K | -363.20K |
| EPS Basic | 0.12 | 0.16 | 0.01 | -0.03 | -0.03 |
| Normalized Basic EPS | 0.05 | -0.04 | 0.01 | -0.02 | -0.03 |
| EPS Diluted | 0.12 | 0.16 | 0.01 | -0.03 | -0.03 |
| Normalized Diluted EPS | 0.03 | -0.02 | 0.00 | -0.02 | -0.03 |
| Average Basic Shares Outstanding | 7.42M | 7.42M | 7.42M | 7.42M | 7.42M |
| Average Diluted Shares Outstanding | 14.85M | 14.51M | 14.42M | 7.42M | 7.42M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |